Hegemonic structure of basic, clinical and patented knowledge on Ebola research: a US army reductionist initiative
David Fajardo-Ortiz, Josw Ortega-Sanchez-de-Tagle, Victor-M Castano

TL;DR
This study maps the organization of Ebola research across basic, clinical, and patent knowledge, revealing a reductionist structure influenced by military interests and highlighting key research fronts and knowledge flow patterns.
Contribution
It introduces a comprehensive network analysis approach to understand Ebola research organization and the influence of military and patent activities on knowledge development.
Findings
Six research fronts identified, including structural proteins and pathogenesis.
Patent network organization mirrors scientific literature, focusing on Ebola virus proteins.
Knowledge flows from clinical-epidemiology to molecular levels, indicating a reductionist approach.
Abstract
Background: In this paper, we present an approach to understand how the basic, clinical and patent knowledge on Ebola is organized and intercommunicated and what leading factor could be shaping the evolution of the knowledge translation process for this disease. Methodology: A combination of citation network analysis; analysis of Medical heading Subject (MeSH) and Gene Ontology (GO) terms, and quantitative content analysis for patents and scientific literature, aimed to map the organization of Ebola research was carried out. Results: We found six putative research fronts (i.e. clusters of high interconnected papers). Three research fronts are basic research on Ebola virus structural proteins: glycoprotein, VP40 and VP35, respectively. There is a fourth research front of basic research papers on pathogenesis, which is the organizing hub of Ebola research. A fifth research front is…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
